# SELLAS Life Sciences Group, Inc.: Form 8-K, filed Mar 28, 2024

- Company: [SELLAS Life Sciences Group, Inc.](/companies/sls.md) (CIK 1390478)
- Form: 8-K
- Filed: 2024-03-28
- Accepted by EDGAR: Mar 28, 2024, 16:08 ET
- Period: 2024-03-28
- Accession: 0001390478-24-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1390478/000139047824000005/sls-20240328.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1390478/000139047824000005/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1390478/000139047824000005/sls-20240328.htm

Filed Mar 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001390478-24-000005. Last ingested by Listed: Nov 13, 2026, 15:18 ET. No prices; not investment advice.
